Browse studies
Find your next paid study
3 recruiting studies matching your filters
MEASuRE: Metreleptin Effectiveness And Safety Registry
The study is a post-authorization, prospective, voluntary registry of patients treated with commercial metreleptin including, but not limited to, patients in t…
Generalised LipodystrophyPartial Lipodystrophy
Amryt PharmaNCT02325674
Phase 3
An Open-label Extension of APG-20 Study to Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in Subjects With Partial Lipodystrophy
This Phase 3 study is an Open Label Extension of the APG-20 Study To Evaluate the Long-term Safety and Efficacy of Daily Subcutaneous Metreleptin Treatment in …
Familial Partial Lipodystrophy
Amryt PharmaNCT06679270
Phase 2
Phase II Study of Growth Hormone Inhibition Using Pegvisomant In Severe Insulin Resistance
Background: Lipodystrophy (LD) syndromes are a group of rare disorders that affect how a person s body can store and use fat tissue. Many people with LDs beco…
Insulin Receptor MutationPartial Lipodystrophy
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT05470504